Add to ORKGIn this double-blind study versus placebo, the anti-migraine efficacy of flunarizine 20 mg/per os/day for 14 days, followed by 10 mg/per os/day up to 120 days has been evaluated in 30 patients suffering from common and classical migraine. During the trial the vestibular function (slow phase velocity (SPV) and number of spikes) was also studied. To date 18 patients have completed the study. The results show a significant difference before and after the treatment with flunarizine, while no difference was observed in the placebo group, with regard to headache unit indices. Flunarizine seems to increase SPV max, which is reduced between attacks in migraine patients; the number of spikes does not change significantly
Based on few clinical trials, flunarizine is considered a first-line prophylactic treatment for migr...
An &month, double-blind, placebo-controlled, crossover trial of flunarizine in the prophylaxis o...
Migraine is characterized by reduced habituation of multimodal evoked potentials, which in turn refl...
In this double-blind study versus placebo, the anti-migraine efficacy of flunarizine 20 mg/per os/da...
Flunarizine, a slow-channel calcium blocker, appeared to be effective in the prophylactic treatment ...
The vestibular function was extensively investigated in 75 patients suffering from migraine. Patholo...
After four weeks of medication-free baseline observation, 29 patients with common migraine randomly ...
Vestibular migraine (VM) is a leading cause of episodic vertigo, affecting up to 1% of the general p...
The effects of flunarizine administration (10 mg/day, at bed time) were studied in 120 common migrai...
In order to assess the effects of flunarizine in long-term prophylaxis of common migraine, 120 subje...
Abstract Objective Novel disease-specific and mechanism-based treatments sharing good evidence of ef...
About one in ten people suffer from attacks of migraine around the world, still, it is one of the mo...
de Beukelaar F on behalf of the Study Group. Efficacy and tolerability in migrain
Objectives: To investigate the effects of valproic acid on vestibular symptoms and electronystagmogr...
An 8-month, double-blind, placebo-controlled, crossover trial of flunarizine in the prophylaxis of m...
Based on few clinical trials, flunarizine is considered a first-line prophylactic treatment for migr...
An &month, double-blind, placebo-controlled, crossover trial of flunarizine in the prophylaxis o...
Migraine is characterized by reduced habituation of multimodal evoked potentials, which in turn refl...
In this double-blind study versus placebo, the anti-migraine efficacy of flunarizine 20 mg/per os/da...
Flunarizine, a slow-channel calcium blocker, appeared to be effective in the prophylactic treatment ...
The vestibular function was extensively investigated in 75 patients suffering from migraine. Patholo...
After four weeks of medication-free baseline observation, 29 patients with common migraine randomly ...
Vestibular migraine (VM) is a leading cause of episodic vertigo, affecting up to 1% of the general p...
The effects of flunarizine administration (10 mg/day, at bed time) were studied in 120 common migrai...
In order to assess the effects of flunarizine in long-term prophylaxis of common migraine, 120 subje...
Abstract Objective Novel disease-specific and mechanism-based treatments sharing good evidence of ef...
About one in ten people suffer from attacks of migraine around the world, still, it is one of the mo...
de Beukelaar F on behalf of the Study Group. Efficacy and tolerability in migrain
Objectives: To investigate the effects of valproic acid on vestibular symptoms and electronystagmogr...
An 8-month, double-blind, placebo-controlled, crossover trial of flunarizine in the prophylaxis of m...
Based on few clinical trials, flunarizine is considered a first-line prophylactic treatment for migr...
An &month, double-blind, placebo-controlled, crossover trial of flunarizine in the prophylaxis o...
Migraine is characterized by reduced habituation of multimodal evoked potentials, which in turn refl...